These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31927504)

  • 1. Uric acid increases IL-1β secretion and Caspase-1 activation in PBMCs of Behçet's disease patients: The in vitro immunomodulatory effect of xanthine oxidase inhibitor Allopurinol.
    Chekaoui A; Belguendouz H; Lahmar K; Mazari F; Terahi M; Hakem D; Youinou P; Touil-Boukoffa C
    Int Immunopharmacol; 2020 Mar; 80():106119. PubMed ID: 31927504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased IL-1β levels are associated with an imbalance of "oxidant/antioxidant" status during Behçet's disease.
    Chekaoui A; Lahmar K; Belguendouz H; Mazari F; Terahi M; Hakem D; Youinou P; Touil-Boukoffa C
    Eur Cytokine Netw; 2018 Sep; 29(3):95-102. PubMed ID: 30547891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro immunomodulatory effects of nicotine on Nitric Oxide, interleukin 1β and interleukin 37 production in human peripheral blood mononuclear cells (PBMC) from patients with Behçet disease.
    Ghozali N; Belguendouz H; Messaoudene D; Hadjimi Z; Ihammichene S; Chekaoui A; Benchabane S; Terahi M; Kediha I; Ali Pacha L; Touil-Boukoffa C
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108189. PubMed ID: 34601327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of interleukin-27 and effect on production of interferon-γ and interleukin-17 in patients with Behçet's disease.
    Shen H; Xia LP; Lu J
    Scand J Rheumatol; 2013; 42(1):48-51. PubMed ID: 23101722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D status in Algerian Behçet's disease patients: an immunomodulatory effect on NO pathway.
    Djeraba Z; Benlabidi F; Djaballah-Ider FZ; Medjeber O; Arroul-Lammali A; Belguendouz H; Otmani F; Touil-Boukoffa C
    Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):243-250. PubMed ID: 28532201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activities of serum adenosine deaminase and xanthine oxidase enzymes in Behcet's disease.
    Sögüt S; Aydin E; Elyas H; Aksoy N; Ozyurt H; Totan Y; Akyol O
    Clin Chim Acta; 2002 Nov; 325(1-2):133-8. PubMed ID: 12367777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
    Deniz R; Tulunay-Virlan A; Ture Ozdemir F; Unal AU; Ozen G; Alibaz-Oner F; Aydin-Tatli I; Mumcu G; Ergun T; Direskeneli H
    Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
    Lucherini OM; Lopalco G; Cantarini L; Emmi G; Lopalco A; Venerito V; Vitale A; Iannone F
    Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased interleukin 27 expression is associated with active uveitis in Behçet's disease.
    Wang C; Tian Y; Ye Z; Kijlstra A; Zhou Y; Yang P
    Arthritis Res Ther; 2014 May; 16(3):R117. PubMed ID: 24887071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LPS-induced Src family kinases activity mediates IL-10 production through activation of STAT3 in peripheral blood mononuclear cells of patients with Behçet's Disease.
    Irtegun Kandemir S; Tekin MA; Bozkurt M; Dagli AZ; Kalkanli-Tas S
    Cell Mol Biol (Noisy-le-grand); 2017 Oct; 63(10):116-121. PubMed ID: 29096751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of allopurinol, uric acid, and inosine administration on xanthine oxidoreductase activity and uric acid concentrations in broilers.
    Settle T; Carro MD; Falkenstein E; Radke W; Klandorf H
    Poult Sci; 2012 Nov; 91(11):2895-903. PubMed ID: 23091148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydralazine improves ischemia-induced neovasculogenesis via xanthine-oxidase inhibition in chronic renal insufficiency.
    Chang TT; Chen JW
    Pharmacol Res; 2020 Jan; 151():104509. PubMed ID: 31678640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice.
    Nishikawa T; Nagata N; Shimakami T; Shirakura T; Matsui C; Ni Y; Zhuge F; Xu L; Chen G; Nagashimada M; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S; Ota T
    Sci Rep; 2020 Jan; 10(1):815. PubMed ID: 31965018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-37 expression is decreased in Behçet's disease and is associated with inflammation.
    Bouali E; Kaabachi W; Hamzaoui A; Hamzaoui K
    Immunol Lett; 2015 Oct; 167(2):87-94. PubMed ID: 26253248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-inflammatory cytokine and caspase-1 responses to pattern recognition receptor activation of neutrophils and dendritic cells in Behcet's disease.
    Türe-Özdemir F; Tulunay A; Elbasi MO; Tatli I; Maurer AM; Mumcu G; Direskeneli H; Eksioglu-Demiralp E
    Rheumatology (Oxford); 2013 May; 52(5):800-5. PubMed ID: 23325038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid levels of uric acid in dogs and the effect of allopurinol.
    Kim P; Yaksh TL; Burnett PC; Blum MR; Sundt TM
    Brain Res; 1987 Jan; 402(1):87-92. PubMed ID: 3828791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher expression of Toll-like receptors 2, 3, 4, and 8 in ocular Behcet's disease.
    Liu X; Wang C; Ye Z; Kijlstra A; Yang P
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6012-7. PubMed ID: 23908180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allopurinol, xanthine oxidase, and cardiac ischemia.
    Lee BE; Toledo AH; Anaya-Prado R; Roach RR; Toledo-Pereyra LH
    J Investig Med; 2009 Dec; 57(8):902-9. PubMed ID: 19794315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthine oxidase inhibition attenuates skeletal muscle signaling following acute exercise but does not impair mitochondrial adaptations to endurance training.
    Wadley GD; Nicolas MA; Hiam DS; McConell GK
    Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E853-62. PubMed ID: 23462817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.
    Doehner W; Schoene N; Rauchhaus M; Leyva-Leon F; Pavitt DV; Reaveley DA; Schuler G; Coats AJ; Anker SD; Hambrecht R
    Circulation; 2002 Jun; 105(22):2619-24. PubMed ID: 12045167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.